Michael M. Hann - Concepedia

Author

Michael M. Hann

GlaxoSmithKline (United Kingdom)ORCID

Also Known As

Hann, M.M., M. Hann, M. M. HANN, M. M. Hann, M.M. Hann, Michael Hann, Michael M Hann, Michael M. Hann

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Hertfordshire GlaxoSmithKline (United States)South College University of Oxford

About

Michael M. Hann is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	2.8K
2	Biochemistry	14	16	1.9K
3	Natural Sciences	12	13	2.3K
4	Engineering	5	5	264
5	Health Sciences	1	1	346

Michael M. Hann

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Type IIA topoisomerase inhibition by a new class of antibacterial agents B.D. Bax, Pan F. Chan, Drake S. Eggleston, Nature Antibacterial AgentsMedicinal ChemistryInhibitory ActivityAntibioticsMedicine	2010	803
RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry Xiao Qing Lewell, Duncan B. Judd, Steve P. Watson, Journal of Chemical Information and Computer Sciences Combinatorial ChemistryHit IdentificationMolecular BiologyComputational ChemistryNew Lead Molecules	1998	687
Molecular obesity, potency and other addictions in drug discovery Michael M. Hann MedChemComm Drug TargetHit IdentificationLead IdentificationLead OptimisationObesity	2011	346
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia György M. Keserű, Daniel A. Erlanson, György G. Ferenczy, Journal of Medicinal Chemistry Pharmaceutical ResearchHit IdentificationMolecular BiologyChemical BiologyFragment Libraries	2016	225
Fragment screening: an introduction Andrew R. Leach, Michael M. Hann, Jeremy N. Burrows, Molecular BioSystems Hit IdentificationLead IdentificationChemistryChemical BiologyFragment Screen	2006	161
Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin Pan F. Chan, Srikannathasan Velupillai, Jianzhong Huang, Nature Communications	2015	153
Behavior of cholesterol and its effect on head group and chain conformations in lipid bilayers: a molecular dynamics study Alexander Robinson, William G. Richards, P. John Thomas, Biophysical Journal Proteinlipid InteractionLipid BiophysicsChain ConformationsBiochemistryLipid Rafts	1995	118
Implementation of a System for Reagent Selection and Library Enumeration, Profiling, and Design Andrew R. Leach, John Bradshaw, Darren V. S. Green, Journal of Chemical Information and Computer Sciences EngineeringAlgorithmic LibraryComputer ArchitectureMolecular BiologySoftware Engineering	1999	88
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery André Mateus, Laurie Gordon, Gareth Wayne, Proceedings of the National Academy of Sciences	2017	87
The Synthesis and Antiviral Activity of 4-Fluoro-1-β-D-ribofuranosyl-1H-pyrazole-3-carboxamide Richard Storer, C. ASHTON, Anthony D. Baxter, Nucleosides and Nucleotides	1999	81

Page 1